Chondroitin Sulfate A-Adhering Plasmodium falciparum-Infected Erythrocytes Express Functionally Important Antibody Epitopes Shared by Multiple Variants

Acquired protection from Plasmodium falciparum placental malaria, a major cause of maternal, fetal, and infant morbidity, is mediated by IgG specific for the P. falciparum erythrocyte membrane protein 1 variant VAR2CSA. This protein enables adhesion of P. falciparum-infected erythrocytes to chondroitin sulfate A in the intervillous space. Although interclonal variation of the var2csa gene is lower than that among var genes in general, VAR2CSA-specific Abs appear to target mainly polymorphic epitopes. This has raised doubts about the feasibility of VAR2CSA-based vaccines. We used eight human monoclonal IgG Abs from affinity-matured memory B cells of P. falciparum-exposed women to study interclonal variation and functional importance of Ab epitopes among placental and peripheral parasites from East and West Africa. Most placental P. falciparum isolates were labeled by several mAbs, whereas peripheral isolates from children were essentially nonreactive. The mAb reactivity of peripheral isolates from pregnant women indicated that some were placental, whereas others had alternative sequestration foci. Most of the mAbs were comparable in their reactivity with bound infected erythrocytes (IEs) and recombinant VAR2CSA and interfered with IE and/or VAR2CSA binding to chondroitin sulfate A. Pair-wise mAb combinations were more inhibitory than single mAbs, and all of the mAbs together was the most efficient combination. Each mAb could opsonize IEs for phagocytosis, and a combination of the eight mAbs caused phagocytosis similar to that of plasma IgG-opsonized IEs. We conclude that functionally important Ab epitopes are shared by the majority of polymorphic VAR2CSA variants, which supports the feasibility of VAR2CSA-based vaccines against placental malaria.

[1]  Terrence J. Sejnowski,et al.  Modelling Vesicular Release at Hippocampal Synapses , 2010, PLoS Comput. Biol..

[2]  Thomas S. Rask,et al.  Plasmodium falciparum Erythrocyte Membrane Protein 1 Diversity in Seven Genomes – Divide and Conquer , 2010, PLoS Comput. Biol..

[3]  A. Salanti,et al.  Can any lessons be learned from the ambiguous glycan binding of PfEMP1 domains? , 2010, Trends in parasitology.

[4]  T. Theander,et al.  Full-Length Recombinant Plasmodium falciparum VAR2CSA Binds Specifically to CSPG and Induces Potent Parasite Adhesion-Blocking Antibodies , 2010, Journal of molecular biology.

[5]  B. Gamain,et al.  Full-length extracellular region of the var2CSA variant of PfEMP1 is required for specific, high-affinity binding to CSA , 2010, Proceedings of the National Academy of Sciences.

[6]  L. Hviid The role of Plasmodium falciparum variant surface antigens in protective immunity and vaccine development , 2010, Human vaccines.

[7]  T. Theander,et al.  The kinetics of antibody binding to Plasmodium falciparum VAR2CSA PfEMP1 antigen and modelling of PfEMP1 antigen packing on the membrane knobs , 2010, Malaria Journal.

[8]  A. Yadouleton,et al.  Insecticide resistance status in Anopheles gambiae in southern Benin , 2010, Malaria Journal.

[9]  M. Wahlgren,et al.  Simultaneous transcription of duplicated var2csa gene copies in individual Plasmodium falciparum parasites , 2009, Genome Biology.

[10]  T. Theander,et al.  Chondroitin sulphate A (CSA)-binding of single recombinant Duffy-binding-like domains is not restricted to Plasmodium falciparum Erythrocyte Membrane Protein 1 expressed by CSA-binding parasites. , 2009, International journal for parasitology.

[11]  Thomas Lavstsen,et al.  Multiple var2csa-Type PfEMP1 Genes Located at Different Chromosomal Loci Occur in Many Plasmodium falciparum Isolates , 2009, PloS one.

[12]  A. Lanzavecchia,et al.  Human monoclonal IgG selection of Plasmodium falciparum for the expression of placental malaria-specific variant surface antigens , 2009, Parasite immunology.

[13]  T. Theander,et al.  Induction of Adhesion-Inhibitory Antibodies against Placental Plasmodium falciparum Parasites by Using Single Domains of VAR2CSA , 2009, Infection and Immunity.

[14]  T. Theander,et al.  VAR2CSA expression on the surface of placenta-derived Plasmodium falciparum-infected erythrocytes. , 2008, The Journal of infectious diseases.

[15]  B. Gamain,et al.  Var2CSA DBL6-epsilon domain expressed in HEK293 induces limited cross-reactive and blocking antibodies to CSA binding parasites , 2008, Malaria Journal.

[16]  P. Andersen,et al.  Identification of glycosaminoglycan binding regions in the Plasmodium falciparum encoded placental sequestration ligand, VAR2CSA , 2008, Malaria Journal.

[17]  Joseph D. Smith,et al.  Evidence for Globally Shared, Cross-Reacting Polymorphic Epitopes in the Pregnancy-Associated Malaria Vaccine Candidate VAR2CSA , 2008, Infection and Immunity.

[18]  Ole Lund,et al.  Structural Insight into Epitopes in the Pregnancy-Associated Malaria Protein VAR2CSA , 2008, PLoS pathogens.

[19]  L. Hviid,et al.  VAR2CSA and protective immunity against pregnancy-associated Plasmodium falciparum malaria , 2007, Parasitology.

[20]  Joseph Bockhorst,et al.  Structural Polymorphism and Diversifying Selection on the Pregnancy Malaria Vaccine Candidate Var2csa , 2007 .

[21]  S. Rogerson,et al.  A novel flow cytometric phagocytosis assay of malaria-infected erythrocytes. , 2007, Journal of immunological methods.

[22]  K. Marsh,et al.  Antibodies among men and children to placental-binding Plasmodium falciparum-infected erythrocytes that express var2csa. , 2007, The American journal of tropical medicine and hygiene.

[23]  Samir N. Patel,et al.  HIV Impairs Opsonic Phagocytic Clearance of Pregnancy-Associated Malaria Parasites , 2007, PLoS medicine.

[24]  L. Hviid,et al.  Malaria in pregnancy: pathogenesis and immunity. , 2007, The Lancet. Infectious diseases.

[25]  P. Andersen,et al.  Human pregnancy-associated malaria-specific B cells target polymorphic, conformational epitopes in VAR2CSA , 2007, Molecular microbiology.

[26]  B. Gamain,et al.  Characterization of anti-var2CSA-PfEMP1 cytoadhesion inhibitory mouse monoclonal antibodies. , 2006, Microbes and infection.

[27]  Ole Lund,et al.  Epitope Mapping and Topographic Analysis of VAR2CSA DBL3X Involved in P. falciparum Placental Sequestration , 2006, PLoS pathogens.

[28]  Stephen J Rogerson,et al.  VAR2CSA is the principal ligand for chondroitin sulfate A in two allogeneic isolates of Plasmodium falciparum. , 2006, Molecular and biochemical parasitology.

[29]  L. Hviid,et al.  Plasmodium falciparum Parasites Expressing Pregnancy-Specific Variant Surface Antigens Adhere Strongly to the Choriocarcinoma Cell Line BeWo , 2006, Infection and Immunity.

[30]  Michael Lanzer,et al.  A single member of the Plasmodium falciparum var multigene family determines cytoadhesion to the placental receptor chondroitin sulphate A , 2005, EMBO reports.

[31]  T. Theander,et al.  High level of var2csa transcription by Plasmodium falciparum isolated from the placenta. , 2005, The Journal of infectious diseases.

[32]  L. Hviid,et al.  Effects of Pregnancy and Intensity of Plasmodium falciparum Transmission on Immunoglobulin G Subclass Responses to Variant Surface Antigens , 2005, Infection and Immunity.

[33]  J. Cox,et al.  Altitude-dependent and -independent variations in Plasmodium falciparum prevalence in northeastern Tanzania. , 2005, The Journal of infectious diseases.

[34]  B. Gamain,et al.  Identification of multiple chondroitin sulfate A (CSA)-binding domains in the var2CSA gene transcribed in CSA-binding parasites. , 2005, The Journal of infectious diseases.

[35]  P. Deloron,et al.  Variable adhesion abilities and overlapping antigenic properties in placental Plasmodium falciparum isolates. , 2004, The Journal of infectious diseases.

[36]  Thor G. Theander,et al.  Evidence for the Involvement of VAR2CSA in Pregnancy-associated Malaria , 2004, The Journal of experimental medicine.

[37]  Joseph D. Smith,et al.  Pregnancy-associated Malaria and the Prospects for Syndrome-specific Antimalaria Vaccines , 2004, The Journal of experimental medicine.

[38]  Venkatachalam Udhayakumar,et al.  The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-saharan Africa. , 2004, The American journal of tropical medicine and hygiene.

[39]  M. Molyneux,et al.  Impairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infection , 2004, The Lancet.

[40]  T. Theander,et al.  Geographical and Temporal Conservation of Antibody Recognition of Plasmodium falciparum Variant Surface Antigens , 2004, Infection and Immunity.

[41]  Kevin Marsh,et al.  Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria , 2004, The Lancet.

[42]  M. Fried,et al.  Antibodies That Inhibit Plasmodium falciparum Adhesion to Chondroitin Sulfate A Are Associated with Increased Birth Weight and the Gestational Age of Newborns , 2003, Infection and Immunity.

[43]  Thomas Lavstsen,et al.  Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A‐adhering Plasmodium falciparum involved in pregnancy‐associated malaria , 2003, Molecular microbiology.

[44]  L. Hviid,et al.  Expression of Variant Surface Antigens by Plasmodium falciparum Parasites in the Peripheral Blood of Clinically Immune Pregnant Women Indicates Ongoing Placental Infection , 2003, Infection and Immunity.

[45]  C. R.J.,et al.  Statistics with Confidence (2nd ed.) , 2003 .

[46]  M. Fried,et al.  Analysis of CSA-binding parasites and antiadhesion antibodies. , 2002, Methods in molecular medicine.

[47]  R. Leke,et al.  Acquisition and decay of antibodies to pregnancy-associated variant antigens on the surface of Plasmodium falciparum-infected erythrocytes that protect against placental parasitemia. , 2001, The Journal of infectious diseases.

[48]  M. Valiyaveettil,et al.  Structural Requirements for the Adherence ofPlasmodium falciparum-infected Erythrocytes to Chondroitin Sulfate Proteoglycans of Human Placenta* , 2000, The Journal of Biological Chemistry.

[49]  T. Theander,et al.  Plasma Antibodies from Malaria-Exposed Pregnant Women Recognize Variant Surface Antigens on Plasmodium falciparum-Infected Erythrocytes in a Parity-Dependent Manner and Block Parasite Adhesion to Chondroitin Sulfate A1 , 2000, The Journal of Immunology.

[50]  M. Smithson Statistics with confidence , 2000 .

[51]  M. Molyneux,et al.  Plasmodium falciparum isolates from infected pregnant women and children are associated with distinct adhesive and antigenic properties. , 1999, The Journal of infectious diseases.

[52]  T. Theander,et al.  Detection of antibodies to variant antigens on Plasmodium falciparum-infected erythrocytes by flow cytometry. , 1999, Cytometry.

[53]  François Nosten,et al.  Maternal antibodies block malaria , 1998, Nature.

[54]  R. Coppel,et al.  An alternative to serum for cultivation of Plasmodium falciparum in vitro. , 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[55]  J. Aguiar,et al.  Agglutination of Plasmodium falciparum-infected erythrocytes from east and west African isolates by human sera from distant geographic regions. , 1992, The American journal of tropical medicine and hygiene.

[56]  H. Groux,et al.  Opsonization as an effector mechanism in human protection against asexual blood stages of Plasmodium falciparum: functional role of IgG subclasses. , 1990, Research in immunology.

[57]  R. Steketee,et al.  RAPID SPONTANEOUS POSTPARTUM CLEARANCE OF PLASMODIUM FALCIPARUM PARASITAEMIA IN AFRICAN WOMEN , 1988, The Lancet.

[58]  D. Warhurst,et al.  SEPARATION OF MALARIA-INFECTED ERYTHROCYTES FROM WHOLE BLOOD: USE OF A SELECTIVE HIGH-GRADIENT MAGNETIC SEPARATION TECHNIQUE , 1981, The Lancet.